the gap in time to patient access for innovative medicines has increased to 864 days between the fastestGermanyand slowestTurkeycountries in Europe.There is also evidence to suggest that,across Europe,delays in availability of innovative medicines are gradually lengthening over timesee Figure 5Error...
(a difference of 696 days).13 Since then,some countries have improved their time until availability,while others have worsened theirs;the overall inequity between countries has persisted.Now,the gap in time to patient access for innovative medicines has increased to 864 days between the fastest( ...